Litigation Details for Eisai Co., Ltd. v. Alkem Laboratories Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Eisai Co., Ltd. v. Alkem Laboratories Ltd. (D. Del. 2019)
| Docket | 1:19-cv-01213 | Date Filed | 2019-06-26 |
| Court | District Court, D. Delaware | Date Terminated | 2019-12-16 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 6,740,669 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Eisai Co., Ltd. v. Alkem Laboratories Ltd.
Details for Eisai Co., Ltd. v. Alkem Laboratories Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-06-26 | External link to document | |||
| 2019-06-26 | 12 | Judgment - Consent | infringement of United States Patent No. 6,740,669 (the "Patent" and such action, the "…JUDGMENT WHEREAS, this action for patent infringement has been brought by Plaintiffs Eisai…Page 2 of 3 PageID #: 52 2. The Patent is enforceable and valid for purposes of the Litigation…any of their Affiliates, until the license to the Patent provided in the Settlement Agreement becomes effective… 16 December 2019 1:19-cv-01213 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-06-26 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1. (nmg) (Entered:… 16 December 2019 1:19-cv-01213 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
